Trial intelligence / Profile preview

Intravenous Ferric Carboxymaltose vs Oral Iron for Postpartum Anemia and Fatigue

NCT07880314Phase 4Completed

Sponsor
PAF Hospital Islamabad
Start
Apr 2026
Primary completion
Sep 2026
Countries
1
01

Overview

A Phase 4 trial of ferric carboxymaltose in iron deficiency anemia (IDA), fatigue, sponsored by PAF Hospital Islamabad. Started Apr 2026; status: completed.

02

Drugs

ferric carboxymaltose
03

Conditions

iron deficiency anemia (IDA)fatigue

Beyond the preview

Go deeper on NCT07880314.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07880314.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call